✦ LIBER ✦

INCIDENCE AND SUBSEQUENT PERSISTENCE OF TARDIVE DYSKINESIA AND EXTRAPYRAMIDAL SYMPTOMS IN SCHIZOPHRENIA IN THE NEW ANTIPSYCHOTICS ERA

✍ Scribed by Diederik Tenback; Peter van Harten; Cees Slooff; Jim van Os

Book ID: 119557545
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 59 KB
Volume: 102
Category: Article
ISSN: 0920-9964
DOI: 10.1016/s0920-9964(08)70727-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analysis of genetic variations in the RG

Analysis of genetic variations in the RGS9 gene and antipsychotic-induced tardive dyskinesia in schizophrenia

✍ Ying-Jay Liou; Mao-Liang Chen; Ying-Chieh Wang; Jen-Yeu Chen; Ding-Lieh Liao; Ya 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

Incidence of tardive dyskinesia is lower

Incidence of tardive dyskinesia is lower with quetiapine treatment than with typical antipsychotics in patients with schizophrenia and schizoaffective disorder

✍ W.M. Glazer; H. Morgenstern; J.A. Pultz; P.P. Yeung; I.W. Rak 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 196 KB

Analysis of genetic variations in the do

Analysis of genetic variations in the dopamine D1 receptor (DRD1) gene and antipsychotics-induced tardive dyskinesia in schizophrenia

✍ I-Ching Lai; Geng-Han Mo; Mao-Liang Chen; Ying-Chieh Wang; Jen-Yeu Chen; Ding-Li 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 124 KB

Remoxipride versus haloperidol in the tr

Remoxipride versus haloperidol in the treatment of acute schizophrenia: The incidence and severity of extrapyramidal symptoms

✍ Morrison, D.; Blomqvist, M.; Gustafsson, B.; Ljungstrom, A.; Westerberg, S.E. 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Incidence and severity of tardive dyskin

Incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia or schizoaffective disorder

✍ R. Sanchez; E. Kim; J. Eudicone; A. Pikalov; E. Vester-Blokland; D.D. Miller 📂 Article 📅 2007 🏛 Elsevier Science 🌐 French ⚖ 46 KB

The role of dopamine D3, 5-HT2A and 5-HT

The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment: Curacao extrapyramidal syndromes study IX

✍ Wilffert, B; Al Hadithy, A.; Sing, V.; Matroos, G; Hoek, H.; van Os, J; Bruggema 📂 Article 📅 2008 🏛 SAGE Publications 🌐 English ⚖ 130 KB